Our Journey | 3Spine

A MOVEMENT IN THE MAKING

1991

Spine surgeons Craig Humphreys and Scott Hodges (H&H) meet at Loyola, where they are exploring spinal anatomy and kinematics with biomechanics researcher Dr. Avinash Patwardhan

1996

Dr. Humphreys joins Dr. Hodges in clinical practice

1999

H&H publish their first paper critical of fusion outcomes, after disappointing experience with revision surgeries

5.1_OurJourney_1999.png
2000

H&H begin experimental work with lumbar motion technologies


5.1_OurJourney_HH.png
2007

H&H publish first lumbar activity of daily living study

5.1-_Our-Journey_2007.png

First seven-patient clinical trial in South Africa

5.1_OurJourney_FirstClinicalTrials.png
2010

Twelve-patient second clinical pilot in South Africa

5.1_OurJourney_SecondClinicalTrials.png
2014

HH Spine LLC takes IP private

2016

Generation 2 development completed, taking advantage of refined instrumentation and surgical technique

International Surgical SEZC acquires HH Spine LLC offshoring technology to the Cayman Islands

Dr. Patwardhan joins International Surgical Board of Directors

2017

International Surgical gains Health Practice Commission approval to enroll third clinical pilot and completes Generation 3 development

International Surgical completes $7.3 million Series A funding

2019

International Surgical completes enrollment of 70-patient third clinical pilot

5.1_OurJourney_ThirdClinicalPilotStudy.png

Publishes sitting assessment tool and additional biomechanical and motion paper

5.1_OurJourney_2019_Study1.png
5.1_OurJourney_2019_Study2.png
2020

International Surgical SEZC rebrands as 3Spine SEZC

3Spine completes $10.0 million Series B

3Spine forms US operating subsidiary 3Spine Management Company, Inc.

Generation 4 Vitamin E antioxidant highly crosslinked PolyEthylene development completed, including implant, instrument, and manufacturing refinements

Generation 4 receives Breakthrough Device Designation from FDA

2021

3Spine acquires NovoClinic Ltd.

3Spine publishes BalancedBack outcomes data

5.1_OurJourney_2021Study.png

3Spine begins enrollment of 150 patient prospective real-world evidence fusion study in the United States

2022

3Spine completes $32M Series-C financing

3Spine becomes 3Spine, Inc.

Move toward a better future

See how MOTUS and our total joint replacement procedure can revolutionize spine care.

Sources